128 related articles for article (PubMed ID: 12811852)
1. A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device.
Confortini M; Bonardi L; Bulgaresi P; Cariaggi MP; Cecchini S; Ciatto S; Cipparrone I; Galanti L; Maddau C; Matucci M; Rubeca T; Troni GM; Turco P; Zappa M; Carozzi F
Cancer; 2003 Jun; 99(3):129-34. PubMed ID: 12811852
[TBL] [Abstract][Full Text] [Related]
2. A feasibility study of the AutoPap system location-guided screening.
Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
[TBL] [Abstract][Full Text] [Related]
3. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
[TBL] [Abstract][Full Text] [Related]
4. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
[TBL] [Abstract][Full Text] [Related]
5. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
[TBL] [Abstract][Full Text] [Related]
6. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
[TBL] [Abstract][Full Text] [Related]
7. Reliability of sparing Papanicolaou test conventional reading in cases reported as No Further Review at AutoPap-assisted cytological screening: survey of 30,658 cases with follow-up cytological screening.
Troni GM; Cariaggi MP; Bulgaresi P; Houssami N; Ciatto S
Cancer; 2007 Apr; 111(2):93-8. PubMed ID: 17330271
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity studies of AutoPap System Location-Guided Screening of cervical-vaginal cytologic smears.
Huang TW; Lin TS; Lee JS
Acta Cytol; 1999; 43(3):363-8. PubMed ID: 10349363
[TBL] [Abstract][Full Text] [Related]
9. Quality control of the autopap screening system employed as a primary screening device: rapid review of smears coded as no further review.
Bulgaresi P; Cariaggi MP; Troni GM; Ciatto S
Tumori; 2006; 92(4):276-8. PubMed ID: 17036515
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory.
Colgan TJ; Patten SF; Lee JS
Acta Cytol; 1995; 39(6):1191-8. PubMed ID: 7483997
[TBL] [Abstract][Full Text] [Related]
11. Performance of the AutoPap Primary Screening System in the detection of high-risk cases in cervicovaginal smears.
Alasio LM; Alphandery C; Grassi P; Ruggeri M; De Palo G; Pilotti S
Acta Cytol; 2001; 45(5):704-8. PubMed ID: 11575647
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System.
Stevens MW; Milne AJ; James KA; Brancheau D; Ellison D; Kuan L
Diagn Cytopathol; 1997 Jun; 16(6):505-12. PubMed ID: 9181316
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of AutoPap system location-guided screening in the evaluation of cervical cytology smears.
Stevens MW; Milne AJ; Parkinson IH; Nespolon WW; Fazzalari NL; Arora N; Dodd TJ
Diagn Cytopathol; 2004 Aug; 31(2):94-9. PubMed ID: 15282720
[TBL] [Abstract][Full Text] [Related]
14. The primary screening clinical trials of the TriPath AutoPap System.
Wilbur DC; Norton MK
Epidemiology; 2002 May; 13 Suppl 3():S30-3. PubMed ID: 12071481
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cells and the AutoPap System for primary screening of cervicovaginal Pap smears.
Walts AE; Thomas P
Diagn Cytopathol; 2002 Oct; 27(4):232-7. PubMed ID: 12357502
[TBL] [Abstract][Full Text] [Related]
16. Validation of AutoPap primary screening system sensitivity and high-risk performance.
Tench WD
Acta Cytol; 2002; 46(2):296-302. PubMed ID: 11917576
[TBL] [Abstract][Full Text] [Related]
17. Location-guided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial.
Wilbur DC; Parker EM; Foti JA
Am J Clin Pathol; 2002 Sep; 118(3):399-407. PubMed ID: 12219782
[TBL] [Abstract][Full Text] [Related]
18. Automated cervical cytology: meta-analyses of the performance of the AutoPap 300 QC System.
Abulafia O; Sherer DM
Obstet Gynecol Surv; 1999 Jul; 54(7):469-76. PubMed ID: 10394585
[TBL] [Abstract][Full Text] [Related]
19. [The use of a computerised system in the reading of cytological cervicovaginals smears during programming of regional screening (one year of experience using the autopap system)].
Orlassino R; Fabbrini T; Gallo C; Vineis C
Pathologica; 2005 Apr; 97(2):78-83. PubMed ID: 16032952
[TBL] [Abstract][Full Text] [Related]
20. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
Bibbo M; Hawthorne C; Zimmerman B
Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
